pharmaceuticals

fda_logo

5 Big FDA Decisions Expected in September

Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, similar to that ...
Read Full Story »
Pills

Short Sellers Have Mixed Feelings on Major Pharma

The short interest data have been released for the August 14 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
research

Epizyme Beats Out the Market With FDA Approval

Epizyme Inc. (NASDAQ: EPZM) survived the market carnage of what was Monday morning’s trading session. In fact this biopharma came out of the fray better off than when it went ...
Read Full Story »
rocket

What Lit a Fire Under These 3 Pharma Stocks

Over the past week, a few pharmaceutical companies made absolutely massive runs. In the past year, the health care sector was on fire from positive trials, U.S. Food and Drug ...
Read Full Story »
Eli Lilly Logo

Eli Lilly Continues to Rise on Positive Jardiance Results

Eli Lilly and Co. (NYSE: LLY) shares got a solid boost in the market Thursday morning as the broad markets were selling off. In fact this major pharmaceutical company has ...
Read Full Story »
biotech

Big Catalysts Coming Within a Week for 2 Specialty Pharmaceutical Stocks

With biotech and specialty pharmaceutical stocks, catalysts and binary events can drive the stocks much higher, or in some cases much lower if the outcome is not what Wall Street ...
Read Full Story »
generic drugs

Is Valeant About to Buy Maker of Female Viagra?

When Sprout Pharmaceuticals received FDA approval for its flibanserin drug earlier this week, it was really just a matter of time before the company either held a public offering of ...
Read Full Story »
fda_logo

How a Fast Track Designation Saved Corbus Pharma

Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) made a quiet entrance into the market last November in its initial public offering that priced for $3.00. Since then Corbus has had a ...
Read Full Story »
Prescription drugs

4 Top Pharma Stocks That Should Outperform Out To 2016

With a very nervous market, and the end of summer doldrums upon us, it may be time to look for ideas that will make sense when the market heats back ...
Read Full Story »
DNA

What the Cord Blood Registry Buyout Really Adds to AMAG

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) had already seen shares rise handily prior to the summer selloff. While this deal is a known event, it looks as though AMAG may have ...
Read Full Story »
health care

Kite Pharma Updates Study, Dispells Rumors

Kite Pharma Inc. (NASDAQ: KITE) gave an update from its ongoing Phase 1/2 clinical trial of KTE-C19 in patients with refractory aggressive non-Hodgkin's lymphoma (NHL) who have failed prior chemotherapy ...
Read Full Story »
investor research

Is AVEO the Next Aquinox for Traders?

AVEO Pharmaceuticals Inc. (NASDAQ: AVEO) made waves in early trading indications Monday on news of a licensing agreement with Novartis A.G. (NYSE: NVS). Both companies announced an exclusive, worldwide license ...
Read Full Story »
biotech

Credit Suisse Sees Big Biopharma Upside in Top Contract Research Outfits

While biotech and certain aspects of the pharmaceutical sectors had done very well up until recent weeks, many health care and biopharma investors seem to have skimmed over or forgotten ...
Read Full Story »
95992888

Why Onconova Is on the Move

Onconova Therapeutics Inc. (NASDAQ: ONTX) announced the submission of an investigational new drug (IND) application to the U.S. Food and Drug Administration (FDA) for IV rigosertib as a treatment for ...
Read Full Story »
Biotechnology word cloud

JPMorgan Has Favorite Biotech Stocks to Buy for Rest of 2015

Despite the market volatility, the biotech sector continues to outperform the broad market, and with the second-quarter earnings reports out of the way, analysts across Wall Street have had a ...
Read Full Story »